Document is current
Any future updates will be listed below
-
Authors
Sharma, Rohini
Alharbi, Sultan N.
Ellum, Ksenia
Motedayen-Aval, Leila
Casadei-Gardini, Andrea
Pinato, David J. https://orcid.org/0000-0002-3529-0103
Bettinger, Dominik
Bengsch, Bertram
Patel, Rishi
Evans, Joanne
-
Funding
Funding for this research was provided by:
Saudi Arabia Cultural Bureau in London
- License Information
-
More Information
Article History
Received: 8 September 2024
Accepted: 21 May 2025
First Online: 1 July 2025
Competing interests
: R.S.: Lecture fees: EISAI, Roche. Travel expenses: Roche. Research funding (to institution) Novartis, Astex Pharmaceuticals, Terumo Europe, Boston Scientific. D.J.P.: Lecture fees: Bayer Healthcare, Astra Zeneca, EISAI, Bristol Myers-Squibb, Roche, Ipsen. Travel expenses: Bristol Myers-Squibb, Roche, Bayer Healthcare. Consulting fees: Mina Therapeutics, Boeringer Ingelheim, Ewopharma, EISAI, Ipsen, Roche, H3B, Astra Zeneca, DaVolterra, Mursla, Avammune Therapeutics, Li.F.T. Biosciences, Exact Sciences. Research funding (to institution): M.S.D., B.M.S., G.S.K.
